Sunday, June 14, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 1016 of 1,261

  1. US 7632484

    Ethylenedicysteine (EC)-drug conjugates, compositions and methods for tissue specific disease imaging

    The Board of Regents of the University of Texas System · Granted Dec 15, 2009 · Expires Dec 10, 2029

    granted

  2. US 7632490

    Use of IL-1 antagonists to treat gout

    REGENERON PHARMACEUTICALS, INC. · Granted Dec 15, 2009 · Expires Dec 10, 2029

    granted

  3. US 7632503

    Method of treating a muscle-related condition with modified IGF1 polypeptides

    REGENERON PHARMACEUTICALS, INC. · Granted Dec 15, 2009 · Expires Dec 10, 2029

    granted

  4. US 7632508

    Attenuated human-bovine chimeric parainfluenza virus (PIV) vaccines

    The United States of America · Granted Dec 15, 2009 · Expires Dec 10, 2029

    granted

  5. US 7632502

    Cell wall mannoproteins and active epitopes from Candida albicans and antibodies recognizing them

    The Board of Regents of the University of Texas System · Granted Dec 15, 2009 · Expires Dec 10, 2029

    granted

  6. US 7632847

    Biphenyl compounds useful as muscarinic receptor antagonists

    Theravance, Inc. · Granted Dec 15, 2009 · Expires Dec 10, 2029

    granted

  7. US 7629336

    Biphenyl compounds useful as muscarinic receptor antagonists

    Theravance, Inc. · Granted Dec 8, 2009 · Expires Dec 3, 2029

    granted

  8. US 7629458

    Preparation of levofloxacin and hemihydrate thereof

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Dec 8, 2009 · Expires Dec 3, 2029

    granted

  9. US 7629308

    Methods relating to muscle selective calcineurin interacting protein (MCIP)

    The Board of Regents of the University of Texas System · Granted Dec 8, 2009 · Expires Dec 3, 2029

    granted

  10. US 7629383

    Double esters

    DRUG DISCOVERY LABORATORY AS · Granted Dec 8, 2009 · Expires Dec 3, 2029

    granted

  11. US 7629005

    Pharmaceutical formulation consisting of a plant dry extract with a calcium coating

    Bionorica AG · Granted Dec 8, 2009 · Expires Dec 3, 2029

    granted

  12. US 7629380

    Antitumor agents

    The Regents of the University of California · Granted Dec 8, 2009 · Expires Dec 3, 2029

    granted

  13. US 7627938

    Tapered hollow metallic microneedle array assembly and method of making and using the same

    The Board of Regents of the University of Texas System · Granted Dec 8, 2009 · Expires Dec 3, 2029

    granted

  14. US 7629168

    Insulin expressing human pancreatic islet cell line capable of reversibly proliferating and use thereof

    Kuraray Medical Inc. · Granted Dec 8, 2009 · Expires Dec 3, 2029

    granted

  15. US 7629323

    Manipulation of neuronal ion channels

    Northwestern University · Granted Dec 8, 2009 · Expires Dec 3, 2029

    granted

  16. US 7626014

    Single-stranded and double-stranded oligonucleotides comprising a 2-arylpropyl moiety

    Alnylam Pharmaceuticals, Inc. · Granted Dec 1, 2009 · Expires Nov 26, 2029

    granted

  17. US 7625736

    Methods for preparing immunogenic conjugates

    The United States of America, as represented by the Department of Health and Human Services · Granted Dec 1, 2009 · Expires Nov 26, 2029

    granted

  18. US 7625696

    Screening method

    Takeda Pharmaceutical Company Limited · Granted Dec 1, 2009 · Expires Nov 26, 2029

    granted

  19. US 7625887

    Receptor agonists

    Takeda Pharmaceutical Company Limited · Granted Dec 1, 2009 · Expires Nov 26, 2029

    granted

  20. US 7625871

    Indole antiviral compositions and methods

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Dec 1, 2009 · Expires Nov 26, 2029

    granted

  21. US 7625913

    Pyrazole compounds useful as protein kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Dec 1, 2009 · Expires Nov 26, 2029

    granted

  22. US 7625571

    Transformed bacteria producing CS6 antigens as vaccines

    The United States of America as represented by the Secretary of the Army · Granted Dec 1, 2009 · Expires Nov 26, 2029

    granted

  23. US 7625575

    Dermatological composition

    Harmony Labs, Inc. · Granted Dec 1, 2009 · Expires Nov 26, 2029

    granted

  24. US 7625563

    Cancer treatment methods using selected immunoconjugates for binding to aminophospholipids

    The Board of Regents of the University of Texas System · Granted Dec 1, 2009 · Expires Nov 26, 2029

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.